Rethinking Drug Discovery: Let’s Collaborate to Shape Tomorrow

CAS connects the world’s scientific knowledge to accelerate breakthroughs that improve lives. As a specialist in knowledge management, our team of scientists and technologists build the largest collection of human curated scientific data in the world. Our specialized content, technology, and expertise help innovators across industries navigate today’s complex information landscape and build a modern data infrastructure that integrates internal and external data sources to accelerate their progress on life changing solutions.

‍

Servier is an independent international pharmaceutical group governed by a foundation. With its governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine lifecycle. 
As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. The Group intends to offer targeted therapeutic solutions, particularly in rare cancers and neurological diseases, and invests nearly 20% of its brand-name sales in R&D. 
Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. 

More information on the Group website: servier.com  

Follow us on social media: LinkedIn, Facebook, X, Instagram